BioPharmaTrend
Latest News
All Topics
  • Artificial Intelligence
  • NeuroTech
  • Premium Content
  • Knowledge Center
Interviews
Companies
  • Company Directory
  • Sponsored Case Studies
  • Create Company Profile
More
  • About Us
  • Our Team
  • Advisory Board
  • Citations and Press Coverage
  • Partner Events Calendar
  • Advertise with Us
  • Write for Us
Subscribe
Login/Join

  Latest News

Creation Healthcare Launches Platform to Analyze Global Social Media Discourse Among Healthcare Professionals

by BiopharmaTrend   •   March 10, 2025  

Disclaimer: All opinions expressed by Contributors are their own and do not represent those of their employers, or BiopharmaTrend.com.
Contributors are fully responsible for assuring they own any required copyright for any content they submit to BiopharmaTrend.com. This website and its owners shall not be liable for neither information and content submitted for publication by Contributors, nor its accuracy.

# HealthTech   
Share:   Share in LinkedIn  Share in Bluesky  Share in Reddit  Share in Hacker News  Share in X  Share in Facebook  Send by email

Creation Healthcare has launched HCP Voice, a real-time analytics platform built to track and interpret the social media conversations of millions of healthcare professionals (HCPs) worldwide. The platform provides pharmaceutical companies with access to specialty-specific, regionally filtered HCP discourse on therapies, trials, manufacturers, and global events—based on data from more than 3 million HCP profiles and nearly 2 billion posts.

#advertisement
AI in Drug Discovery Report 2025

HCP Voice expands Creation’s product line following the September 2024 launch of DOL Finder, a tool designed to identify and rank influential digital opinion leaders in disease-specific conversations such as type 2 diabetes. The two platforms together aim to give life sciences teams detailed visibility into both individual HCP influence and collective discussion dynamics.

See also: A New Tool to Spot Influential Healthcare Professionals in Pharma

In a demonstration focused on type 2 diabetes, HCP Voice revealed that endocrinologists dominated online engagement, with conversations centering on GLP-1 and SGLT2 inhibitors. The platform also identified high-impact trials like FLOW, STEP, and SELECT, along with engagement trends tied to major congresses. Users can filter data by time, region, language, and medical specialty, enabling companies to tailor engagement strategies around treatment launches, trial announcements, or conference follow-ups.

Beyond tracking product mentions and sentiment, the platform provides heatmaps, linguistic analysis, and insight into top-shared resources and accounts, offering pharma teams the tools to refine marketing approaches and anticipate emerging topics in clinician discourse.

Topics: HealthTech   

Share:   Share in LinkedIn  Share in Bluesky  Share in Reddit  Share in Hacker News  Share in X  Share in Facebook  Send by email
#advertisement
ThermoFisher Scientific: Integrated genetic technologies for cell therapy development
#advertisement
Webinar: AI in Clinical Trials

BiopharmaTrend.com

Where Tech Meets Bio
mail  Newsletter
in  LinkedIn
x  X
gnews  Google News
rss  RSS Feed

About


  • What we do
  • Citations and Press Coverage
  • Terms of Use
  • Privacy Policy
  • Disclaimer

We Offer


  • Premium Content
  • BioTech Scout
  • Interviews
  • Partner Events
  • Case Studies

Opportunities


  • Membership
  • Advertise
  • Submit Company
  • Write for Us
  • Contact Us

© BPT Analytics LTD 2025
We use cookies to personalise content and to analyse our traffic. You consent to our cookies if you continue to use our website. Read more details in our cookies policy.